Lawrence Williams

Cost Effectiveness of Aspirin, Clopidogrel, or Both for Secondary Prevention of Coronary Heart Disease

Jean-Michel Gaspoz, Pamela G. Coxson, Paula A. Goldman et al. · New England Journal of Medicine · 2002 · 294 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +12

Cost-Effectiveness of Cholesterol-Lowering Therapies according to Selected Patient Characteristics

Lisa A. Prosser, Aaron A. Stinnett, Paula A. Goldman et al. · Annals of Internal Medicine · 2000 · 250 citations

Pharmacy, Pharmacoeconomics, Preventive Medicine +17

Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer’s disease

Peter J. Neumann, Richard C. Hermann, Karen M. Kuntz et al. · Neurology · 1999 · 244 citations

Pharmacy, Pharmacoeconomics, Psychiatry +17

Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines

Andrew E. Moran, Michelle C. Odden, Anusorn Thanataveerat et al. · New England Journal of Medicine · 2015 · 239 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +17

Expected gains in life expectancy from various coronary heart disease risk factor modifications.

Joel Tsevat, Milton C. Weinstein, Lawrence Williams et al. · Circulation · 1991 · 215 citations · Full text

Medicine, Chronic Disease Prevention, Preventive Medicine +16